The pharmaceutical landscape for diabetes is changing, and transdermal GLP-1 delivery systems represent a promising breakthrough. Unlike injections, this approach offers a simpler way to provide GLP-1 therapies. https://arunnygl045493.blogerus.com/62920129/glp-1-patches-a-novel-approach-to-glucose-management